| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 88.885 | 73 |
| GSM780708 | Untreated after 4 days (C2_1) | 81.7051 | 72 |
| GSM780709 | Untreated after 4 days (C3_1) | 80.6856 | 72 |
| GSM780719 | Untreated after 4 days (C1_2) | 83.4996 | 72 |
| GSM780720 | Untreated after 4 days (C2_2) | 87.2508 | 73 |
| GSM780721 | Untreated after 4 days (C3_2) | 92.7144 | 74 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 91.5114 | 74 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 93.6049 | 74 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 87.761 | 73 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 79.1236 | 71 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 89.9717 | 74 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 83.2092 | 72 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 84.8785 | 73 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 77.2507 | 71 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 90.3272 | 74 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 115.429 | 77 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 82.6435 | 72 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 85.6763 | 73 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 97.2322 | 75 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 93.0424 | 74 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 85.6763 | 73 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 105.937 | 76 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 86.8663 | 73 |